29 patents
Page 2 of 2
Utility
Farnesoid X Receptor Agonists and Uses Thereof
16 Sep 20
Described herein are compounds that are farnesoid X receptor agonists, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with farnesoid X receptor activity.
Nicholas D. SMITH, Stephen P. GOVEK, Johnny Y. NAGASAWA
Filed: 27 May 20
Utility
Farnesoid X receptor agonists and uses thereof
6 Jul 20
Described herein are compounds that are farnesoid X receptor agonists, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with farnesoid X receptor activity.
Nicholas D. Smith, Steven P. Govek, Johnny Y. Nagasawa
Filed: 15 Sep 16
Utility
Ssao Inhibitors and Uses Thereof
10 Jun 20
Described herein are compounds that are semicarbazide-sensitive amine oxidase (SSAO) inhibitors, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in treating or preventing a liver disease or condition.
Nicholas D. Smith, Andrew R. Hudson, Mi Chen, Johnny Y. Nagasawa, Iriny Botrous
Filed: 13 Feb 20
Utility
Farnesoid X Receptor Agonists and Uses Thereof
29 Apr 20
Described herein are compounds that are farnesoid X receptor agonists, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with farnesoid X receptor activity.
Nicholas D. SMITH, Steven P. GOVEK, Johnny Y. NAGASAWA, Andiliy G. LAI
Filed: 13 Mar 18
Utility
Farnesoid X Receptor Agonists and Uses Thereof
29 Apr 20
Described herein are compounds that are farnesoid X receptor agonists, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with farnesoid X receptor activity.
Nicholas D. SMITH, Steven P. GOVEK, Johnny Y. NAGASAWA
Filed: 13 Mar 18
Utility
Farnesoid X Receptor Agonists and Uses Thereof
29 Apr 20
Described herein are compounds that are farnesoid X receptor agonists, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with farnesoid X receptor activity.
Nicholas D. SMITH, Steven P. GOVEK, Johnny Y. NAGASAWA
Filed: 13 Mar 18
Utility
Farnesoid X Receptor Agonists and Uses Thereof
29 Apr 20
Described herein are compounds that are farnesoid X receptor agonists, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with farnesoid X receptor activity.
Nicholas D. SMITH, Steven P. GOVEK, Johnny Y. NAGASAWA, Karensa L. Douglas
Filed: 13 Mar 18
Utility
Farnesoid X receptor agonists and uses thereof
20 Apr 20
Described herein are compounds that are farnesoid X receptor agonists, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with farnesoid X receptor activity.
Nicholas D. Smith, Steven P. Govek, Johnny Y. Nagasawa
Filed: 15 Sep 16
Utility
Farnesoid X Receptor Agonists and Uses Thereof
1 Apr 20
Described herein are compounds that are farnesoid X receptor agonists, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with farnesoid X receptor activity.
Nicholas D. SMITH, Steven P. GOVEK, Karensa L. DOUGLAS, Andiliy G. LAI
Filed: 16 Sep 19